What to Ask About Cannabis Extract Quality and Testing

Extract quality matters because a product can only be judged safely if patients and clinicians know what is actually in it. With cannabis extracts, the label is not always the whole story.

Key takeaways

• Quality is about more than strength.
• A good product should have a clear batch identity, declared cannabinoids, and a proper testing trail.
• Certificates of analysis are useful, but they are not a substitute for proper manufacturing standards.
• Unlicensed products carry more uncertainty about consistency and contamination.
• If a seller cannot explain testing, be cautious.

Evidence base

NHS England says unlicensed cannabis-based products for medicinal use have not had their quality assessed by the regulator. That is the key patient issue: without a proper quality trail, it is harder to know whether a product contains the amount stated, whether it is contaminated, or whether later batches will behave the same way.

MHRA guidance for unlicensed CBPM imports says a Certificate of Analysis should support the batch specification, and a valid GMP certificate should be in place for the manufacturing site. In practice, that is the kind of paperwork patients and prescribers want to see when a product is being positioned as a medicinal option rather than a consumer supplement.

This is why quality questions are medical questions, not just shopping questions.

What patients should know

If you are considering a cannabis extract, ask:

• What is the exact product name and batch number?
• What are the THC and CBD contents?
• Is there a recent Certificate of Analysis?
• Was the product made under GMP?
• Has it been tested for microbes, heavy metals, pesticides, and residual solvents?
• How should it be stored, and when does it expire?
• What happens if a batch is recalled or reformulated?

Also ask whether the extract is suitable for your route of use. A product that looks similar on paper may behave differently when swallowed, vaporised, or used in another form.

Be careful with claims such as "pure", "full spectrum", or "pharmaceutical grade" if no testing details are offered. Those words can sound reassuring while telling you very little.

If you are using a product bought online or from a non-medical seller, check whether the label is specific enough to match what you are actually taking. Vague labelling makes it harder to spot overexposure, contamination, or product substitution.

When to speak to a clinician

Speak to a clinician if:

• you are unsure whether the product has been properly tested
• the label does not match how the product feels
• you develop side effects after a batch change
• you want to switch from one extract to another
• you have liver disease, mental health concerns, or other medicines that could interact
• you are pregnant, breastfeeding, or need to drive

If the product has no clear testing information, do not treat that as a minor paperwork issue. It may change the safety picture.

Source trail

• NHS England: Cannabis-based products for medicinal use (CBPMs): unlicensed products have not had their quality assessed by the regulator.
• GOV.UK: Cannabis guidance for unlicensed CBPMs: Certificate of Analysis and GMP expectations for imports.
• GOV.UK: Drug licensing factsheet - cannabis, CBD and other cannabinoids
• MHRA statement on products containing cannabidiol (CBD)
• Yellow Card scheme: report suspected medicine side effects and product concerns.